Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
| ID3 | HAND1 | HAND1, EHAND: Heart- and neural crest derivatives-expressed protein 1 | 137.0 | Evidence | |||||
| ID3 | HES6 | HES6: Transcription cofactor HES-6 | 119.0 | Evidence | |||||
| ID3 | TAL2 | TAL2: T-cell acute lymphocytic leukemia protein 2 | 119.0 | Evidence | |||||
| ID3 | TCF3 | TCF3, E2A, ITF1: Transcription factor E2-alpha | 109.0 | Evidence |
|
||||
| ID3 | ID2 | ID2: DNA-binding protein inhibitor ID-2 | 102.0 | Evidence | |||||
| ID3 | ID1 | ID1, ID: DNA-binding protein inhibitor ID-1 | 98.40 | Evidence | |||||
| ID3 | MYF5 | MYF5: Myogenic factor 5 | 78.20 | Evidence |
O
|
||||
| ID3 | TAL1 | TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 | 78.20 | Evidence | |||||
| ID3 | ID4 | ID4: DNA-binding protein inhibitor ID-4 | 60.60 | Evidence |
|
||||
| ID3 | TCF12 | TCF12, HEB, HTF4: Transcription factor 12 | 27.80 | Evidence |
|
||||
| ID3 | TCF21 | TCF21, POD1: Transcription factor 21 | 27.80 | Evidence | |||||
| ID3 | ASCL3 | ASCL3, HASH3, SGN1: Achaete-scute homolog 3 | 24.10 | Evidence | |||||
| ID3 | BHLHB8 | BHLHB8, MIST1: Class B basic helix-loop-helix protein 8 | 24.10 | Evidence | |||||
| ID3 | TWIST1 | TWIST1, TWIST: Twist-related protein 1 | 17.90 | Evidence | |||||
| ID3 | TCF4 | TCF4, ITF2, SEF2: Transcription factor 4 | 17.90 | Evidence |
|
||||
| ID3 | TCF15 | TCF15, BHLHEC2: Transcription factor 15 | 17.90 | Evidence | |||||
| ID3 | LYL1 | LYL1: Protein lyl-1 | 15.80 | Evidence | |||||
| ID3 | HAND2 | HAND2, DHAND: Heart- and neural crest derivatives-expressed protein 2 | 15.80 | Evidence | |||||
| ID3 | NHLH2 | NHLH2, HEN2: Helix-loop-helix protein 2 | 15.80 | Evidence | |||||
| ID3 | ASCL2 | ASCL2: Achaete-scute homolog 2 | 15.80 | Evidence | |||||
| ID3 | MEF2D | MEF2D: Myocyte-specific enhancer factor 2D | 11.20 | Evidence | |||||
| ID3 | CREBBP | CREBBP, CBP: CREB-binding protein | 7.43 | Evidence | |||||
| ID3 | CDC6 | CDC6, CDC18L: Cell division control protein 6 homolog | 5.66 | Evidence | |||||
| ID3 | CALM2 | CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca | 4.04 | Evidence | |||||
| ID3 | FOSL2 | FOSL2, FRA2: Fos-related antigen 2 | 3.55 | Evidence | |||||
| ID3 | MCM3 | MCM3: DNA replication licensing factor MCM3 | 3.07 | Evidence | |||||
| ID3 | PHTF1 | PHTF1, PHTF: Putative homeodomain transcription factor 1 | 2.62 | Evidence | |||||
| ID3 | CDC25A | CDC25A: M-phase inducer phosphatase 1 | 2.54 | Evidence | |||||
| ID3 | CDK7 | CDK7, MO15: Cell division protein kinase 7 | 2.34 | Evidence | |||||
| ID3 | FZR1 | N/A | 2.34 | Evidence | |||||
| ID3 | GATA2 | N/A | 2.34 | Evidence | |||||
| ID3 | CDC7 | CDC7, CDC7L1: Cell division cycle 7-related protein kinase | 1.9 | Evidence | |||||
| ID3 | HES1 | HES1, HL, HRY: Transcription factor HES-1 | 1.72 | Evidence |
|
||||
| ID3 | MLXIPL | MLXIPL, MIO, WBSCR14: Williams-Beuren syndrome chromosome region 14 protein | 1.13 | Evidence | |||||
| ID3 | ARNT | ARNT: Aryl hydrocarbon receptor nuclear translocator | 1.13 | Evidence | |||||
| ID3 | MAX | MAX: Protein max | 1.13 | Evidence | |||||
| ID3 | NCOA3 | NCOA3, AIB1, RAC3, TRAM1: Nuclear receptor coactivator 3 | 1.13 | Evidence | |||||
| ID3 | TFAP4 | TFAP4: Transcription factor AP-4 | 1.13 | Evidence | |||||
| ID3 | HIF1A | HIF1A, MOP1: Hypoxia-inducible factor 1 alpha | 1.04 | Evidence | |||||
| ID3 | AHR | AHR: Aryl hydrocarbon receptor precursor | 1.04 | Evidence | |||||